Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
Cannabis is more legal now than ever before. Yet, it remains under-researched and stigmatized. The “Cannabis Education and Research Collection” seeks to close the gap between cutting-edge research and public knowledge of the plants’ vast potential by highlighting the perspectives and expertise of the next generation of cannabis professionals who will push the industry forward in the coming decades.
You’re invited to submit a paper for possible publication by Veriheal in our “Cannabis Education and Research Collection.” Veriheal is a healthcare technology company that is the largest facilitator of medical marijuana cards in the nation. Our accompanying blog aims to provide comprehensive education, resources, and knowledge regarding a wide variety of topics related to cannabis and alternative wellness.
For this collection, we welcome research on a range of themes, including but not restricted to:
Discoveries around cannabinoid pharmacology and the medicinal benefits of the cannabis plant
The impact of cannabis legalization from a social science perspective
BIPOC experiences in cannabis education and research
Innovations in cannabis growth and cultivation
Cannabis use by special populations, such as adolescents, pregnant people, individuals with mental health disorders, and older adults, among others
The chemical composition of cannabis strains, profiling cannabinoids, terpenes, and other phytochemicals, and exploring their potential synergistic effects on therapeutic outcomes
Implications for the future of public health, including patterns of use, prevalence of cannabis-related disorders, access to healthcare services, and public perceptions of cannabis use.
If you’re a current student who is a member of a cannabis-related major or doing research about cannabis within your field, we want to hear from you. Papers should be approximately 1000-1500 words in length and formatted according to the Associated Press Stylebook.
We seek to help people live better lives by changing the stigma on cannabis. Our aim is to change the image of alternative medicine by creating more ease for all users, more growth in science, more access for all patients, and more transparency in the industry.
Planning a Puerto Rico getaway and want to stay compliant with local cannabis rules? Good call. Puerto Rico is a U.S. territory with a medical cannabis program (no recreational sales). The island recognizes specific out-of-state patient credentials and also offers a short-term “travel med card” option so that qualified visitors can purchase legally at licensed…
Historically, cannabis culture grew out of an underground legacy formed in response to staunch opposition and long-standing federal prohibition of the plant. Almost half of U.S. states now allow adult-use legalization, blending cannabis’s original subversive, anti-establishment attitude with modern institutional, legal, and corporate frameworks. The spread of cannabis jargon into unfamiliar spaces always introduces funky…
In the decades before marijuana legalization began to spread across the United States, the legacy market (formerly known as the black or illicit market) was the go-to place for people to purchase cannabis. It was an industry filled with people from all walks of life, who partook for an even wider variety of reasons. Some…
Lubricants reduce friction, increase pleasure, and decrease discomfort during sexual activities. They come in water-based, oil-based, or silicone-based varieties to meet customers’ varied needs. But did you know that cannabis-infused lubricants (also known as lube) are also options on the market? Made with tetrahydrocannabinol (THC), these products combine the typical lube experience with the effects…
Claims that younger generations have more chronic health conditions have been circling for years. Earlier this year, National Geographic reported that more than one billion people between the ages of 10 and 24 are at risk of poor health outcomes by 2030, which accounts for about half of the global adolescent population. The original study…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.